GYROSCOPE THERAPEUTICS
Gyroscope is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye. The company explores the convergence of advancements made in the understanding of the complement system’s impact on eye disease, the genetic basis of Age-related Macular Degeneration (AMD), and gene therapy as a mode of treatment delivery. Its lead investigational gene therapy, GT005, is a one-time therapy delivered under the retina. GT005 is designed to restore balance to an o... veractive complement system by increasing the production of the Complement Factor I protein. GT005 is currently being evaluated in a Phase I/II clinical trial called FOCUS and Phase II clinical trials called EXPLORE and HORIZON. Andrew Lotery, David Kavanagh, and Peter Lachmann co-founded Gyroscope Therapeutics in Stevenage, Herefordshire in 2016.
GYROSCOPE THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Therapeutics
Founded:
2016-01-01
Address:
Stevenage, Herefordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.gyroscopetx.com
Total Employee:
101+
Status:
Active
Contact:
+44 (0)1438 906770
Email Addresses:
[email protected]
Total Funding:
269.52 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
NorthSea Therapeutics
NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.
Regulus Therapeutics
Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-04-11 | Orbit Biomedical | Orbit Biomedical acquired by Gyroscope Therapeutics | N/A |
Investors List
Sanofi
Sanofi investment in Corporate Round - Gyroscope Therapeutics
Syncona Partners LLP
Syncona Partners LLP investment in Series C - Gyroscope Therapeutics
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Series C - Gyroscope Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series C - Gyroscope Therapeutics
Tetragon Financial Group Limited
Tetragon Financial Group Limited investment in Series C - Gyroscope Therapeutics
T. Rowe Price
T. Rowe Price investment in Series C - Gyroscope Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Series C - Gyroscope Therapeutics
Fosun Pharma
Fosun Pharma investment in Series C - Gyroscope Therapeutics
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Series B - Gyroscope Therapeutics
Syncona Partners LLP
Syncona Partners LLP investment in Series B - Gyroscope Therapeutics
Official Site Inspections
http://www.gyroscopetx.com Semrush global rank: 3.26 M Semrush visits lastest month: 5.05 K
- Host name: 104.18.26.220
- IP address: 104.18.26.220
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
